Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease

NCT04088240 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Supplements Expired

Conditions

Elevated Triglycerides
Cardiovascular Risk Factor

Interventions

DIETARY_SUPPLEMENT: DPA enriched n-3
DIETARY_SUPPLEMENT: n-3 control
DIETARY_SUPPLEMENT: Placebo

Sponsor

University of Arizona